HPGC Renmintongtai Pharmaceutical (SHSE:600829) Cyclically Adjusted Book per Share: ¥3.89 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600829 HPGC Renmintongtai Pharmaceutical Corp SHSE:600829
55 GF Score
Price ¥9.01
GF Value ¥7.84
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is HPGC Renmintongtai Pharmaceutical Cyclically Adjusted Book per Share?

HPGC Renmintongtai Pharmaceutical SHSE:600829 55 Cyclically Adjusted Book per Share is ¥3.89 as of Mar. 2026. GuruFocus rates SHSE:600829 with a GF Score™ of 55/100 and a GF Value™ of ¥7.84 (Modestly Overvalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

HPGC Renmintongtai Pharmaceutical's adjusted book value per share for the three months ended in Mar. 2026 was ¥5.283. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥3.89 for the trailing ten years ended in Mar. 2026.

During the past 12 months, HPGC Renmintongtai Pharmaceutical's average Cyclically Adjusted Book Growth Rate was 7.50% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 2.80% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 1.70% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 1.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of HPGC Renmintongtai Pharmaceutical was 13.00% per year. The lowest was 0.70% per year. And the median was 3.20% per year.

As of today (2026-07-21), HPGC Renmintongtai Pharmaceutical's current stock price is ¥9.01. HPGC Renmintongtai Pharmaceutical's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was ¥3.89. HPGC Renmintongtai Pharmaceutical's Cyclically Adjusted PB Ratio of today is 2.32.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of HPGC Renmintongtai Pharmaceutical was 5.23. The lowest was 1.46. And the median was 2.11.


HPGC Renmintongtai Pharmaceutical  (SHSE:600829) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

HPGC Renmintongtai Pharmaceutical's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=9.01/3.89
=2.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of HPGC Renmintongtai Pharmaceutical was 5.23. The lowest was 1.46. And the median was 2.11.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


HPGC Renmintongtai Pharmaceutical Cyclically Adjusted Book per Share Related Terms


HPGC Renmintongtai Pharmaceutical Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for HPGC Renmintongtai Pharmaceutical's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HPGC Renmintongtai Pharmaceutical Cyclically Adjusted Book per Share Chart

HPGC Renmintongtai Pharmaceutical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.48 3.52 3.54 3.55 3.82

HPGC Renmintongtai Pharmaceutical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.62 3.67 3.75 3.82 3.89

SHSE:600829 vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, HPGC Renmintongtai Pharmaceutical's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HPGC Renmintongtai Pharmaceutical Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, HPGC Renmintongtai Pharmaceutical's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where HPGC Renmintongtai Pharmaceutical's Cyclically Adjusted PB Ratio falls into.


SHSE:600829
55GF Score
HPGC Renmintongtai Pharmaceutical Corp SHSE:600829
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HPGC Renmintongtai Pharmaceutical Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, HPGC Renmintongtai Pharmaceutical's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=5.283/116.3033*116.3033
=5.283

Current CPI (Mar. 2026) = 116.3033.

HPGC Renmintongtai Pharmaceutical Quarterly Data

Book Value per Share CPI Adj_Book
201606 2.671 101.400 3.064
201609 2.790 102.400 3.169
201612 2.842 102.600 3.222
201703 2.455 103.200 2.767
201706 2.581 103.100 2.912
201709 2.701 104.100 3.018
201712 2.780 104.500 3.094
201803 2.900 105.300 3.203
201806 2.511 104.900 2.784
201809 2.628 106.600 2.867
201812 2.725 106.500 2.976
201903 2.851 107.700 3.079
201906 2.967 107.700 3.204
201909 3.086 109.800 3.269
201912 3.186 111.200 3.332
202003 3.269 112.300 3.386
202006 3.325 110.400 3.503
202009 3.428 111.700 3.569
202012 3.436 111.500 3.584
202103 3.505 112.662 3.618
202106 3.551 111.769 3.695
202109 3.720 112.215 3.856
202112 3.794 113.108 3.901
202203 3.874 114.335 3.941
202206 3.977 114.558 4.038
202209 4.125 115.339 4.159
202212 4.241 115.116 4.285
202303 4.372 115.116 4.417
202306 4.513 114.558 4.582
202309 4.663 115.339 4.702
202312 4.745 114.781 4.808
202403 4.880 115.227 4.926
202406 4.834 114.781 4.898
202409 4.956 115.785 4.978
202412 4.969 114.893 5.030
202503 5.048 115.116 5.100
202506 5.094 114.907 5.156
202509 5.161 115.471 5.198
202512 5.199 115.832 5.220
202603 5.283 116.303 5.283

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ¥3.89 mean?
HPGC Renmintongtai Pharmaceutical (SHSE:600829) has a Cyclically Adjusted Book per Share of ¥3.89 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on HPGC Renmintongtai Pharmaceutical and its competitors.
Is HPGC Renmintongtai Pharmaceutical's Cyclically Adjusted Book per Share too high?
HPGC Renmintongtai Pharmaceutical's current Cyclically Adjusted Book per Share is ¥3.89. Overall, HPGC Renmintongtai Pharmaceutical has a GF Score™ of 55/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does HPGC Renmintongtai Pharmaceutical's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
HPGC Renmintongtai Pharmaceutical's Cyclically Adjusted Book per Share of ¥3.89 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on HPGC Renmintongtai Pharmaceutical and its competitors. HPGC Renmintongtai Pharmaceutical's current Cyclically Adjusted Book per Share is ¥3.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HPGC Renmintongtai Pharmaceutical stock overvalued right now?
Based on GuruFocus' analysis, HPGC Renmintongtai Pharmaceutical (SHSE:600829) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥7.84, compared to a current price of ¥9.01 — trading 14.9% above its estimated fair value. The current Cyclically Adjusted Book per Share is ¥3.89. HPGC Renmintongtai Pharmaceutical's overall GF Score™ is 55/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For HPGC Renmintongtai Pharmaceutical (SHSE:600829), the current Cyclically Adjusted Book per Share is ¥3.89 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HPGC Renmintongtai Pharmaceutical (SHSE:600829) Overvalued in 2026?

Based on GuruFocus' analysis, HPGC Renmintongtai Pharmaceutical stock appears to be overvalued. The current stock price of ¥9.01 is trading 14.9% above its estimated GF Value™ of ¥7.84. GuruFocus considers HPGC Renmintongtai Pharmaceutical to be Modestly Overvalued.

Key valuation signals for SHSE:600829:

  • Cyclically Adjusted Book per Share: ¥3.89
  • GF Value™: ¥7.84 vs. price of ¥9.01 (14.9% above fair value)
  • GF Score™: 55/100 with 2 warning signs

No single metric tells the full story. See the SHSE:600829 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


HPGC Renmintongtai Pharmaceutical Business Description

Address No. 76 Hengshan Road, Nangang District, Heilongjiang Province, Harbin, CHN, 150076
HPGC Renmintongtai Pharmaceutical Corp, formerly Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co Ltd is engaged in the production and sale of pharmaceuticals products in China.
55GF Score

Get the complete analysis for SHSE:600829

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥9.01
Price
¥7.84
GF Value